We have located links that may give you full text access.
Radiomics-based machine learning in the differentiation of benign and malignant bowel wall thickening radiomics in bowel wall thickening.
Japanese Journal of Radiology 2024 March 28
PURPOSE: To distinguish malignant and benign bowel wall thickening (BWT) by using computed tomography (CT) texture features based on machine learning (ML) models and to compare its success with the clinical model and combined model.
METHODS: One hundred twenty-two patients with BWT identified on contrast-enhanced abdominal CT and underwent colonoscopy were included in this retrospective study. Texture features were extracted from CT images using LifeX software. Feature selection and reduction were performed using the Least Absolute Shrinkage and Selection Operator (LASSO). Six radiomic features were selected with LASSO. In the clinical model, six features (age, gender, thickness, fat stranding, symmetry, and lymph node) were included. Six radiomic and six clinical features were used in the combined model. Classification was done using two machine learning algorithms: Support Vector Machine (SVM) and Logistic Regression (LR). The data sets were divided into 80% training set and 20% test set. Then, training took place with all three datasets. The model's success was tested with the test set consisting of features not used during training.
RESULTS: In the training set, the combined model had the best performance with the area under the curve (AUC) value of 0.99 for SVM and 0.95 for LR. In the radiomic-derived model, the AUC value is 0.87 in SVM and 0.79 in LR. In the clinical model, SVM made this distinction with 0.95 AUC and LR with 0.92 AUC value. In the test set, the classifier with the highest success distinguishing malignant wall thickening is SVM in the radiomic-derived model with an AUC value of 0.90. In other models, the AUC value is in the range of 0.75-0.86, and the accuracy values are in the range of 0.72-0.84.
CONCLUSION: In conclusion, radiomic-based machine learning has shown high success in distinguishing malignant and benign BWT and may improve diagnostic accuracy compared to clinical features only. The results of our study may help ensure early diagnosis and treatment of colorectal cancers by facilitating the recognition of malignant BWT.
METHODS: One hundred twenty-two patients with BWT identified on contrast-enhanced abdominal CT and underwent colonoscopy were included in this retrospective study. Texture features were extracted from CT images using LifeX software. Feature selection and reduction were performed using the Least Absolute Shrinkage and Selection Operator (LASSO). Six radiomic features were selected with LASSO. In the clinical model, six features (age, gender, thickness, fat stranding, symmetry, and lymph node) were included. Six radiomic and six clinical features were used in the combined model. Classification was done using two machine learning algorithms: Support Vector Machine (SVM) and Logistic Regression (LR). The data sets were divided into 80% training set and 20% test set. Then, training took place with all three datasets. The model's success was tested with the test set consisting of features not used during training.
RESULTS: In the training set, the combined model had the best performance with the area under the curve (AUC) value of 0.99 for SVM and 0.95 for LR. In the radiomic-derived model, the AUC value is 0.87 in SVM and 0.79 in LR. In the clinical model, SVM made this distinction with 0.95 AUC and LR with 0.92 AUC value. In the test set, the classifier with the highest success distinguishing malignant wall thickening is SVM in the radiomic-derived model with an AUC value of 0.90. In other models, the AUC value is in the range of 0.75-0.86, and the accuracy values are in the range of 0.72-0.84.
CONCLUSION: In conclusion, radiomic-based machine learning has shown high success in distinguishing malignant and benign BWT and may improve diagnostic accuracy compared to clinical features only. The results of our study may help ensure early diagnosis and treatment of colorectal cancers by facilitating the recognition of malignant BWT.
Full text links
Related Resources
Trending Papers
Haemodynamic monitoring during noncardiac surgery: past, present, and future.Journal of Clinical Monitoring and Computing 2024 April 31
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.Circulation 2024 May 9
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app